Treatment of dilated cardiomyopathy caused by coronary microvascular dysfunction with anisodamine: a report of 5 cases  

作　　者：Xu Zhiwei Wang Tong Chen Liang Lou Ying Sun Xiaoyan Jiang Jinqi 

机构地区：[1]Department of Cardiac Surgery,Huai'an First People's Hospital,The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University,Huai'an,223000,China [2]Department of Emergency,Shanghai Chest Hospital,Shanghai Jiaotong University,Shanghai 200030,China [3]Department of Nuclear Medicine,Shanghai Chest Hospital,Shanghai Jiaotong University,Shanghai 200030,China

出　　处：《Journal of Traditional Chinese Medicine》2020年第2期340-342,共3页中医杂志（英文版）

摘　　要：The management of dilated cardiomyopathy(DCM) is well established. However, a subset of patients does not have recovery from or have recurrences of left ventricular(LV) dysfunction despite receiving optimal medical therapy. Coronary microvascular dysfunction(CMD) can result from structural and functional abnormalities at the intramural and small coronary vessel level affecting coronary blood flow autoregulation and consequently leading to impaired coronary flow reserve. Dilated myocardial phenotype may be responsible for CMD in DCM. Anisodamine can exert a significant effect on relieving microvascular spasm, and improving and dredging the coronary microcirculation. However,whether CMD can be potentially improved with anisodamine to make DCM better remains incompletely understood.

关 键 词：ANISODAMINE Coronary microvascular dysfunction Cardiomyopathy dilated Case reports 

分 类 号：R542.2[医药卫生—心血管疾病]